| Whereabouts are you from? purchase fertile xx Celgene Corp, up 6.7 percent to $133.48, was amongthe top performers for both the S&P 500 and the Nasdaq 100 after the company said a late-stage trial of its cancerdrug, Revlimid, met the main goal of improving survival in newlydiagnosed blood cancer patients.
|